Xsphera Biosciences and NEX-I Collaborate to Advance Oncology Drug Research

Xsphera Biosciences, a leading biotechnology company specializing in ex vivo testing of oncology therapeutics on patient-excised tumor tissue, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with NEX-I